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Introduction: Within the last decades, collagen types I and III have been established as a sufficient biomaterial for GBR
and GTR procedures. They might also be an adequate matrix for soft tissue augmentations. However, collagen
materials differ significantly regarding resorption time, biodegradation pattern and the invasion of inflammatory cells.
The aim of the present study was to compare the biodegradation and tissue integration of native, differently processed
and cross-linked collagen scaffolds in rats.
Methods: Four experimental porcine collagen matrices of 1.0 mm thickness, developed for soft tissue augmentation
procedures, were tested. Based on the same native dermal Type I and III collagen, native (ND, Mucoderm® prototype),
specifically defatted (DD), ethylene dioxide cross-linked (ECL) and dehydrothermally cross-linked (DCL) dermis collagen
(AAP/Botiss Biomaterials, Berlin, Germany) were evaluated. Two specimens of 1 × 1 cm were fixed around a non-absorbable
spacer using non-absorbable sutures. After rehydration, specimens (N = 8) were randomly allocated in unconnected
subcutaneous pouches on the back of 40 Wistar rats. Rats were divided into five groups (1, 2, 4, 8 and 12 weeks), including
eight animals each. After each period, eight rats were sacrificed and explanted specimens were prepared for histological
analysis. The following parameters were evaluated: membrane thickness as a sign of biodegradation and volume stability,
cell ingrowth, vascularization, tissue integration and foreign body reaction.
Results: Biodegradation pattern of the non cross-linked collagen scaffolds differed only slightly in terms of presence of
inflammatory cells and cell invasion into the matrix. In terms of biodegradation, ECL displayed a considerable slower
resorption than ND, DCL and DD. Chemical cross-linking using ethylene dioxide showed a significant higher invasion
of inflammatory cells.
Conclusion: Within the limits of the present study it was concluded that the processing techniques influenced the
collagen properties in a different intensity. Dehydrothermal cross-linking and special defatting did not notably change
the biodegradation pattern, whereas cross-linking using ethylene dioxide led to significant higher volume stability of
the matrix. However, ECL showed an increased inflammatory response and compromised tissue integration. Therefore,
ethylene dioxide seems to be not suitable for stabilization of collagen matrices for soft tissue augmentation procedures.
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In periodontology and implantology bone and soft tissue
augmentation procedures are often necessary to achieve
aesthetic and functional results. Regarding bone augmen-
tation Guided Bone and Tissue Regeneration (GBR/GTR)
have been established as a comparable alternative to the
gold standard, i.e. grafting of autogenous bone [1-5]. The
concept of GBR/GTR procedures include the use of bone
substitute materials and covering the grafting site with an
absorbable membrane. This membrane separates cells
with regenerative potential, like osteoblasts and desmo-
dontal fibroblasts, from rapidly proliferating epithelial and
connective tissue cells. Different membrane materials have
been investigated and collagen has proven to be a promis-
ing substance for GBR procedures. As native collagen
shows a lack of immunogenicity [6], collagen can be har-
vested from different donor species and be transferred to
humans without immunological response. Postlethwaite
et al. [7] pointed out that the advantages of collagen lie in
its haemostatic function, chemotactic properties to attract
periodontal ligament fibroblasts and gingival fibroblasts as
well as semi permeability and support of nutrient transfer.
Furthermore, collagen plays an important role in coagu-
lum formation and is a major component of the periodon-
tal connective tissue [8-10]. It also seemed to surpass
other materials in design criteria for GBR/GTR such as
biocompatibility, tissue integration, cell-occlusivity, vol-
ume stability and easy use in the clinical routine [11].
Moreover, native collagen type I/III showed good biocom-
patibility in vitro and in vivo [12] as well as fast
vascularization and revitalization [13,14].
In terms of soft tissue augmentation the use of soft tis-
sue grafts is an accepted routine in implantology and
periodontal surgery not only in order to decrease or
neutralize pain deriving from soft tissue loss but also be-
cause of functional and aesthetic aspects [15-18]. As a
result of soft tissue thickening the translucency of re-
storative materials or discoloured devital teeth and the
occurrence of recessions are reduced [16]. Soft tissue
augmentation procedures are usually performed by har-
vesting either autologous free gingival [19] or connective
tissue grafts [20]. These procedures are often accompan-
ied by an additional donor site pain [21] and complica-
tions like bleeding due to damage of the branches of the
palatine artery, necrosis of the mucosa and hyp- or an-
aesthesia [18]. The quantity and quality of the trans-
plants is individually different and naturally limited [22].
To avoid the aforementioned donor site morbidity and
being able to enhance soft tissue regardless of individual
prerequisites collagen matrices can also be used for soft
tissue augmentations procedures. In contrast to the au-
togenous grafts, collagen matrices are unlimitedly avail-
able and can be produced with a constant quality. In a
clinical study performed by Sanz et al. [23] the use ofcollagen matrices to enhance the width of keratinized
gingiva was compared with free connective tissue grafts.
Clinical outcome was comparable for both groups. However,
patients who were treated by collagen matrices suffered sig-
nificantly less pain and the total time of surgery was re-
duced, since no autogenous grafts had to be harvested.
Collagen matrices that are used for soft tissue aug-
mentations have to show adequate volume stability in
order to allow enough time for cells to invade into the
collagen matrix and to build new soft tissue. In line with
the GTR/GBR membranes, rapid biodegradation might
be also a disadvantage. Tatakis et al. [24] marked the fast
biodegradation caused by the enzymatic activity (collage-
nase) of macrophages and polymorphonuclear leuko-
cytes as the greatest demerit of native collagen [24].
However, resorption time of collagen can be extended by
cross-linking of the collagen fibres using physical, thermic
or chemical procedures. Previous studies investigated dif-
ferently cross-linked GTR/GBR membranes and found
substantial differences regarding biodegradation, biocom-
patibility and angiogenesis. In this context cross-linking
using glutaraldehyde decreased the biocompatibility
whereas enzymatic cross-linking negatively reduced the
tissue integration and biodegradation pattern. The de-
gree of chemical cross-linking correlated with higher
volume stability, but caused severe inflammatory reac-
tions [25]. Moreover, a higher inflammatory response
was found when collagen scaffolds were not sufficiently
defatted.
The aim of the present study was to investigate new
kinds of collagen scaffolds stabilization, i.e. ethylene diox-
ide and dehydrothermal cross-linking as well as a special
defatting protocol including acetone treatment, and to
compare these techniques to native type I/III collagen.
Materials and methods
Animals
Forty albino rats of the Wistar strain (age 3 + - 0.5 months,
weight 350 +/- 21 g) were used in the present study. Ani-
mal selection, management, and surgery protocol were ap-
proved by the Animal Care and Use Committee of the
local government of Dusseldorf (LANUV, reference num-
ber 87-51.04.2010.A139), Germany. The animals were di-
vided into five groups (1, 2, 4, 8, 12 weeks), including
eight rats each.
Membranes examined
Four experimental porcine collagen matrices of 1.0 mm
thickness, developed for soft tissue augmentation proce-
dures, were tested. Based on the same native dermal
Type I and III collagen tissue, native (ND, Mucoderm®
Prototype), specifically defatted (DD), ethylene dioxide
cross-linked (ECL) and dehydrothermally cross-linked
(DCL) dermis collagen (AAP/Botiss Biomaterials, Berlin,
Figure 2 Subcutaneous preparation of four unconnected pouches.
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were fixed around a non-absorbable polycarbonate spacer
(Isopore®, Millipore Corporate, Billerica, MA, USA) using
non-absorbable sutures (Seralon®, Resorba, Nuremberg,
Germany) for easier retrieval after longer healing periods
(Figure 1). The specimens were circumferentially sutured
to avoid an ingrowth of the surrounding tissue. After rehy-
dration in 0.9% sterile saline solution (Braun, Melsungen,
Germany), specimens (N = 8) were randomly allocated in
unconnected subcutaneous pouches separated surgically
on the back of 40 Wistar rats.
Surgical procedure
The animals were anesthetized by intraperitoneal injec-
tion of 9 mg/kg ketamine 10% (Ketanest®, Pfizer GmbH,
Karlsruhe, Germany) and 5 mg/kg xylazine 2% (Sedaxylan®,
Pfizer GmbH). Following disinfection of the back with
polyvidone iodine (Betaisodona®, Mundipharma, Limburg
a.d. Lahn, Germany), a skin incision was made exactly
paramedian along the vertebral column (Figure 2) followed
by the separation of four unconnected subcutaneous
pouches (Figure 3). The membranes were randomly allo-
cated in the resulting 160 pouches (Figure 4). Primary
wound closure was achieved using horizontal mattress
3.0 Vicryl sutures (Resorba, Nurnberg, Germany). Dur-
ing the experiment, the animals were fed ad libitum
with standard laboratory food pellets. Animals were
sacrificed in a carbon dioxide euthanasia chamber after
1, 2, 4, 8, and 12 weeks. Residues of the membranes
were removed with the surrounding connective tissue
(Figure 5) and fixed in 10% formalin.
Histomorphometry
An experienced research associate, blinded to the spe-
cific experimental conditions, performed the histomor-
phometrical analysis and microscopic examination. All
specimens were embedded in paraffin. Four histological
sections were systemically and randomly cut from eachFigure 1 Paravertebral incision for graft implantation.specimen. The resulting serial sections of 7 μm thickness
were stained with Goldner Trichrome stain, respectively HE
stain. For image acquisition a colour CCD camera (Color-
View III, Olympus, Hamburg, Germany) was mounted on a
binocular light microscope (Olympus BX50, Olympus).
Digital images were evaluated using an imaging program
(Cell D, Soft Imaging System, Muenster, Germany). Before
the histomorphometrical analysis, a calibration procedure
was initiated for the image analysis software, revealing that
repeated measurements of n = 12 different sections were
similar at >95% level.
The thickness of the membrane body was measured
linearly at 12 fields selected at random. Additionally,
the following parameters were evaluated descriptively:
vascularization of the membrane body, tissue integra-
tion and foreign body reaction (i.e. presence of multinu-
cleated giant cells). Cell invasion was classified in five
categories and graphically processed as a box plot figure.
Histological specimens that showed cell invasion only in
the outer third of the collagen scaffold were classified into
the first category. Accordingly, category 2 and 3 showedFigure 3 Collagen matrices were marked and fixed around a
polycarbonate spacer using a non-resorbable polyester suture.
Figure 4 Specimens were rehydrated and carefully allocated
into subcutaneous pockets.
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sion of the collagen scaffold. Category 4 was assigned
to homogenous spreading of cells within the collagen
body, whereas category 5 represented complete biodeg-
radation of the membranes.
Statistical analysis
A statistical software (SPSS 22.0, SPSS Inc., Chicago, IL,
USA) was used for the statistical analysis. Mean values and
standard deviations were calculated for each group regard-
ing membrane thickness. Analysis of variance (ANOVA)
and post hoc testing by Bonferroni's correction for multiple
comparisons were used for comparisons within groups.
Results were considered statistically significant at P < 0.05.
Results
Postoperative healing
The postoperative healing was uneventful in all rats.
No complications were observed, including infection,
bleeding, allergic reactions or dehiscences.Figure 5 Native dermal collagen after 4 weeks of healing, revealing
good tissue integration and macroscopic ingrowth of blood vessels.Macroscopic analysis
Harvested residues of specimens revealed good tissue
integration for all groups. After 1, 2 and 4 weeks matri-
ces were embedded in an inflammation-free layer of
subcutaneous tissue, revealing small blood vessels
within the matrix and along the surface of the collagen
(Figure 5). After 8 and 12 weeks, EDC revealed no
macroscopic change of matrix thickness, whereas ND,
DD and DCL showed significant reduction of the
collagen.Histomorphometrical analysis
Thickness of matrix bodies for each group at different
healing periods is presented in Figure 6. Histomorphome-
trical analysis revealed that scaffold thickness of all tested
scaffolds showed no considerable reduction two weeks fol-
lowing implantation in each group (P > 0.05 respectively).
Histomorphometrical analysis failed to demonstrate a re-
duction of scaffold thickness of ECL during the entire
study period of twelve weeks (P > 0.05). ND, DD and DCL
showed significant changes of scaffold thickness after four
weeks following implantation (P < 0.001 respectively).
Cell invasion and biodegradation values are represented
in boxplots due to their non-parametric characteristics
(Figure 7). After one week, all matrices revealed cell inva-
sion less than the first third of the matrix. ND and DD
showed faster invasion of cells after 2 and 4 weeks,
whereas ECL and DCL started to being organized more
than the first third earliest after four weeks. ND, DD and
DCL displayed complete biodegradation after 12 weeks,
whereas ECL revealed a homogenous organisation and no
signs of matrix collapse at this time.Figure 6 Bars representing means and standard deviations
(in nm) of thickness of different collagen matrices after 1, 2, 4,
8 and 12 weeks.
Figure 7 Boxplots representing cell invasion and matrix
organization of different collagen matrices (1: < 1/3, 2: < 2/3,
3: < 3/3 of matrix thickness, 4: homogenous organization,
5: complete biodegradation).
Figure 8 Native dermal collagen (ND) shows excellent tissue
integration and initial cell invasion after 2 weeks healing
period (Masson Goldner, orig. magn. 200×). CM: collagen matrix,
MT: muscle tissue, *: blood vessel.
Figure 9 Single invasion of a multinucleated giant cell in a
dehydrothermally cross-linked matrix after 2 weeks healing
period (Masson Goldner, orig. magn. 200×). CM: collagen matrix,
MT: muscle tissue, *: blood vessel, #: multinucleated giant cell.
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One-week specimens
One week following implantation, three of the scaffolds
(ND, DD, DCL) did not show substantial differences regard-
ing the membrane structure. These membranes presented a
porous structure with smaller and larger interconnected
spaces. ECL presented a slightly denser structure. All four
scaffolds displayed a physiological post-traumatic inflamma-
tory reaction in the tissue neighbouring the external surface,
the most prominent cells being neutrophil granulocytes and
macrophages. Some ND specimens demonstrated a slight
vascularization of the superficial portion of the scaffold.
Two-week specimens
After two weeks, large areas of ND and DD were in-
vaded by blood vessels and scattered neutrophil granulo-
cytes and macrophages (Figure 8). Mononucleated cells
invading the outer parts of the collagen scaffolds could
be detected in increasing areas also of DCL, partly show-
ing single multinucleated cells in between the collagen
strains (Figure 9). Blood vessels ingrowth from the sur-
rounding connective tissues could be also detected. ECL
presented only superficial cell invasion, less tissue inte-
gration and almost no blood vessel ingrowth into the
dense collagen scaffold.
Four-week specimens
After four weeks, histological analysis demonstrated a
homogenous cell invasion of ND and DD. Most of these
scaffolds were almost completely biodegraded and orga-
nized by newly formed connective tissue. For DCL a bio-
degradation of 50% could be noted. ECL scaffolds did
not show any changes in thickness or collagen structure,but cell invasion could be detected in the outer thirds.
Regarding neo-angiogenesis ND and DD appeared com-
pletely vascularized and also most parts of DCL dis-
played clear signs of vascularization. The appearance of
inflammatory cells was limited to isolated macrophages
and granulocytes for ND, DD and ECL, whereas DCL
demonstrated a significantly higher foreign body reac-
tion, with high numbers of multinuclear giant cells even
reaching the inner surface of the scaffold.
Eight-week specimens
Eight weeks following implantation ND, DD and DCL
were completely organized and almost entirely replaced
by newly formed connective tissue (Figure 10). The ECL
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matrix thickness as implanted, showing homogenous cell
invasion and blood vessel ingrowth reaching the inner
surface of the matrix. However, a high concentration of
multinucleated giant cells were visible around the indi-
vidual collagen strains, representing a strong foreign
body reaction.Figure 11 Complete biodegradation of ND after 12 weeks
healing period (Masson Goldner, Original magn. 200×). CM:
collagen matrix, MT: muscle tissue, *: blood vessel, CT: connective
tissue, S: spacer, A: artefact.Twelve-week specimens
After twelve weeks, ND, DD and DCL matrix were
completely biodegraded and only a thin fibrous layer
was visible between the spacer and the surrounding
connective tissue (Figure 11). ECL showed only small
changes in regards of membrane thickness, its collagen
structure was more porous and presented some areas
of fatty degeneration. The matrix was homogenously
invaded blood vessels, but also a high number of multi-
nucleated giant cells were visible inside the entire
matrix body (Figure 12).Discussion
In the present animal study biodegradation, vascularization
and tissue integration of native, differently processed and
cross-linked collagen scaffolds were evaluated in a subcuta-
neous rat model. Within its limits, the results revealed that
native, non cross-linked collagen showed a fast tissue inte-
gration and vascularization paired with slight to no signs of
ingrowing inflammatory cells. Native and defatted types I
and III collagens were almost completely resorbed after
12 weeks. This is in accordance to previous studies,
which also found high biocompatibility and fast biodeg-
radation for native, non cross-linked collagens, i.e. after
insertion into surgical pouches of mongrel dogs, whereFigure 10 Advanced biodegradation and no foreign body
reaction on DD after 8 weeks healing period (Masson Goldner,
orig. magn. 100×). CM: collagen matrix, MT: muscle tissue, *: blood
vessel, CT: connective tissue, S: spacer, A: artefact.the specimens revealed severe to moderate degradation
within 4-8 weeks [26].
In contrast to native collagen, cross-linked collagen
matrices have shown longer biodegradation times in pre-
vious studies. Chemical cross-linking using glutaralde-
hyde and enzymatic cross-linking was able to enhance
the stability of collagen matrices [27]. However, it was
displayed that cross-linking also influences the biological
properties of collagen scaffolds. In an experimental study
performed in rats different cross-linking techniques were
compared to native collagen scaffolds. Membranes con-
sisting of collagen type I, which were enzymatically
cross-linked by ribose enzymes did not present any signsFigure 12 High number of multinucleated giant cells and
advanced blood vessel invasion in the ECL matrix after
12 weeks healing period (Masson Goldner, orig. magn. 200×).
CM: collagen matrix, MT: muscle tissue, *: blood vessel, CT:
connective tissue.
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blood vessel ingrowth or cell invasion. Glutaraldehyde
cross-linking led to limited tissue integration and was ac-
companied by a higher degree of inflammatory response
[25]. Clinically, chemical cross-linking was accompanied
by more adverse events such as wound dehiscences, graft
exposure and insufficient bone regeneration [28], based
on the compromised tissue integration.
In the present study cross-linking using ethylene diox-
ide (ECL) demonstrated a longer resorption time, in line
with earlier results accompanied by more inflammatory
response and foreign body reaction. Tissue integration
was compromised in the shorter healing periods, and
multinucleated giant cells as a sign for foreign body re-
action were found within the entire collagen scaffold,
but thickness of the matrix scaffold remained stable dur-
ing the entire study period.
But not only changed properties due to the cross-
linking techniques can influence the biodegradation pat-
tern of collagen scaffolds. Also a higher collagen density
can be a reason for slower biodegradation. Scaffolds con-
sisting of the same native collagen qualities, but differing
in the density of collagen fibres, showed longer resorption
times when derived from anatomically denser harvesting
tissues [12]. Porous membranes offer less resistance to in-
vading cells and blood vessels, allow for better nutrient
transfer and therefore are organized faster than denser
membranes [29]. ECL displayed a higher density in the
histological examination and thus impeded cells from in-
vading into the scaffolds for the first four weeks. But as
the denser collagen structure might be a result of the
ethylene dioxide treatment, cross-linking using ethylene
dioxide seems to influence biodegradation patterns on
several levels.
Defatting of collagen and dehydrothermal cross-linking
did not show large differences to native collagen scaffolds.
Besides comparable histomorphometrical measurements
regarding membrane thickness and invasion of cells, both
groups also appeared almost similar in the histological
evaluation. The fast biodegradation might be a result of
the collagen type I and III combined with a porous
structure. Also dehydrothermally cross-linked three-
dimensional collagen matrices were observed to de-
grade faster than chemically cross-linked scaffolds [30].
However, in contrast to defatted and native collagen,
DHC displayed a slightly higher inflammatory response,
hypothetically based on the thermal impact on biocom-
patibility of the collagen. This might be a disadvantage
of dehydrothermal cross-linking.
As a drawback of the present study it has to be stated
that all results were achieved in a rat model. It was dem-
onstrated that results regarding foreign body reaction
are different depending on the animal model. Mice,
which were treated by a cross-linked dermal collagen,presented less signs of foreign body reaction, i.e. fewer
formation of giant cells, than different strains of rats
[31]. Furthermore, a clinical study that examined non
cross-linked bovine type I collagen in humans revealed de-
viant results to previous animal studies. The membranes
were intentionally exposed to the oral environment. After
one week no residuals of the native membranes could be
detected [32]. This is contrary to animal studies that usu-
ally found resorption times of several weeks. But the fast
resorption can be explained by the presence of peri-
odontal pathogens such as Porphyromonas gingivalis
and Treponema denticola. These pathogens were ob-
served to produce collagenases and thus promote a pre-
mature degradation of collagen [33]. However, these
circumstances only apply in case of exposure to the oral
cavity. As collagen matrices, in terms of soft tissue
augmentation procedures, and they are ideally covered by
soft tissue after flap advancement, therefore subcutaneous
implantation in rats might still be an adequate model.
Clinical relevance
The clinical gold standard in terms of soft tissue augmen-
tation is the use of autogenous grafts harvested from the
palate [15-18]. However, harvesting of these grafts is ac-
companied by donor site morbidity and increased stress
for the patients [18,21]. Searching for non-autologous al-
ternatives, native collagen types I and III have shown ex-
cellent biocompatibility and tissue integration in GTR and
GBR procedures. Collagen types I and II of human origin
have shown predictable results when used for recession
coverage [34,35], increasing the width of keratinized gin-
giva, [36] and aesthetic soft tissue augmentations [37,38].
When a xenogeneic tissue grafting material is used,
inflammation-free biodegradation is an even more import-
ant aspect. A native porcine types I and II collagen matrix
revealed predictable results in enhancing the width of ker-
atinized gingiva, reducing patient morbidity and operation
time [23]. In the present study, an ethylene dioxide cross-
linked matrix showed the longest volume stability, but also
highest inflammatory response and foreign body reaction.
Clinically, this might lead to higher rates of dehiscences
and other wound healing complications as described for
chemically cross-linked collagen used for GBR procedures
[39]. Also a dehydrothermal cross-linking technique led to
a higher inflammatory response, thus – from the clinical
point of view - a native porcine collagen matrix seems to
be the best option for artificial soft tissue augmentation
procedures even if the volume stability is lower than with
non-cross-linked collagen.
Conclusions
Within the limits of the present study it was concluded
that even if resulting in longer biodegradation times,
ethylene dioxide cross-linking seems to be not suitable for
Rothamel et al. Head & Face Medicine 2014, 10:10 Page 8 of 9
http://www.head-face-med.com/content/10/1/10stabilization of collagen used for soft tissue augmentation
procedures, due to its slow tissue integration and inflam-
matory biodegradation pattern. Defatting using acetone
and dehydrothermal cross-linking did not enhance bio-
logical properties of native types I and III collagen in
terms of tissue integration or long term stability.
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